Batanopride (BMY 25801) is a selective 5-HT 3 receptor antagonist. Batanopride inhibits chemotherapy-induced emesis, and prevents Cisplatin ( HY-17394 )-, Cyclophosphamide ( HY-17420 )-, Doxorubicin ( HY-15142A )-, and total body irradiation-induced emesis.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > 5-HT Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.